THERAPY RELATED ACUTE LEUKAEMIA WITH MITOXANTRONE: 4 YEARS ON, WHAT IS THE RISK AND CAN IT BE LIMITED?

Richard James Ellis; Sean Brown; Mike Boggild

doi:10.1136/jnnp-2013-306573.28

Article info

Association of British Neurologists (ABN) joint meeting with the Royal College of Physicians (RCP), London, 23–24 October 2013

028

THERAPY RELATED ACUTE LEUKAEMIA WITH MITOXANTRONE: 4 YEARS ON, WHAT IS THE RISK AND CAN IT BE LIMITED?

Authors

Richard James Ellis Leighton Hospital, Crewe; Countess of Chester, Chester; The Townsville Hospital, Queensland, Australia PubMed articles Google scholar articles
Sean Brown Leighton Hospital, Crewe; Countess of Chester, Chester; The Townsville Hospital, Queensland, Australia PubMed articles Google scholar articles
Mike Boggild Leighton Hospital, Crewe; Countess of Chester, Chester; The Townsville Hospital, Queensland, Australia PubMed articles Google scholar articles

Citation

Ellis RJ, Brown S, Boggild M

THERAPY RELATED ACUTE LEUKAEMIA WITH MITOXANTRONE: 4 YEARS ON, WHAT IS THE RISK AND CAN IT BE LIMITED?

Journal of Neurology, Neurosurgery & Psychiatry 2013;84:e2.

Publication history

First published October 9, 2013.

Online issue publication

April 04, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password